Related Experiment Videos
Rhinovirus and the lower respiratory tract
1University of Virginia School of Medicine, Hospital Drive, Private Clinics Building, Room 6557, PO Box 800473, Charlottesville, Virginia 22908, USA. fgh@virginia.edu
Reviews in Medical Virology
|January 13, 2004
Summary
Human rhinoviruses (HRVs) cause common colds and can also infect the lower respiratory tract. This review highlights HRV
Area of Science:
- Virology
- Immunology
- Pulmonology
Background:
- Human rhinoviruses (HRVs) are primary causes of upper respiratory tract infections, commonly known as the common cold.
- HRVs are associated with various complications, including sinusitis and otitis media.
- Emerging evidence suggests HRVs also play a significant role in lower respiratory tract illnesses.
Purpose of the Study:
- To review and synthesize current information on the link between HRV infection and lower respiratory tract diseases.
- To explore the pathogenesis of HRV infections in the lower airways.
- To identify gaps in knowledge regarding HRV-associated lower respiratory tract complications in specific patient populations.
Main Methods:
- Review of existing scientific literature, including in vitro studies, in situ hybridization, and clinical investigations.
- Analysis of data on HRV replication, immune response modulation, and clinical outcomes.
- Identification of patient groups with limited information on HRV-related lower respiratory tract illness.
Main Results:
- HRVs replicate efficiently in bronchial epithelial cells, triggering cytokine and chemokine release.
- HRV infections are frequently implicated in infant pneumonia and bronchiolitis, and commonly exacerbate asthma and COPD.
- HRV infections contribute significantly to asthma exacerbations and hospitalizations across age groups.
Conclusions:
- HRV infections extend beyond the upper respiratory tract, causing significant lower respiratory tract morbidity.
- Further research is needed to understand HRV pathogenesis in severe lower respiratory tract illness, particularly in older adults and immunocompromised individuals.
- Development of safe and effective antiviral therapies for HRV prevention and treatment is a critical unmet medical need.